- Home
- CMPX vs FSBW Comparison
CMPX vs FSBW Comparison
Compare CMPX & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FSBW
- Stock Information
- Founded
- CMPX 2014
- FSBW 1936
- Country
- CMPX United States
- FSBW United States
- Employees
- CMPX N/A
- FSBW N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FSBW Banks
- Sector
- CMPX Health Care
- FSBW Finance
- Exchange
- CMPX Nasdaq
- FSBW Nasdaq
- Market Cap
- CMPX 291.8M
- FSBW 293.8M
- IPO Year
- CMPX N/A
- FSBW 2012
- Fundamental
- Price
- CMPX $2.61
- FSBW $41.44
- Analyst Decision
- CMPX Strong Buy
- FSBW Hold
- Analyst Count
- CMPX 9
- FSBW 1
- Target Price
- CMPX $12.67
- FSBW $44.00
- AVG Volume (30 Days)
- CMPX 946.0K
- FSBW 16.4K
- Earning Date
- CMPX 08-11-2025
- FSBW 07-22-2025
- Dividend Yield
- CMPX N/A
- FSBW 2.70%
- EPS Growth
- CMPX N/A
- FSBW N/A
- EPS
- CMPX N/A
- FSBW 4.31
- Revenue
- CMPX $850,000.00
- FSBW $139,608,000.00
- Revenue This Year
- CMPX N/A
- FSBW $8.34
- Revenue Next Year
- CMPX N/A
- FSBW $5.99
- P/E Ratio
- CMPX N/A
- FSBW $9.64
- Revenue Growth
- CMPX N/A
- FSBW 0.22
- 52 Week Low
- CMPX $0.77
- FSBW $33.36
- 52 Week High
- CMPX $4.08
- FSBW $49.15
- Technical
- Relative Strength Index (RSI)
- CMPX 60.92
- FSBW 53.13
- Support Level
- CMPX $2.52
- FSBW $38.57
- Resistance Level
- CMPX $2.71
- FSBW $39.93
- Average True Range (ATR)
- CMPX 0.17
- FSBW 0.61
- MACD
- CMPX 0.00
- FSBW 0.14
- Stochastic Oscillator
- CMPX 68.64
- FSBW 65.65
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.